Anacor Pharmaceuticals, Inc. Appoints Paul L. Berns to Its Board of Directors

Published: Jun 04, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today the appointment of Paul L. Berns to its Board of Directors. Since 2006, Mr. Berns has served as the President, Chief Executive Officer, and a member of the Board of Directors of Allos Therapeutics, a biopharmaceutical company focused on developing and commercializing anti-cancer therapeutics.

Back to news